mTOR Inhibitors May Extend Human Health Span

D

Dr. Joan Mannick on InsideTracker's Channel

Anti-AgingMedical

Quotes From Source

“Dr. Joan Mannick is currently CEO at Tornado Therapeutics where they develop safer more...”

Story of claim

Dr. Joan Mannick, CEO of Tornado Therapeutics, is developing safer and more effective mTOR inhibitors to extend human health span. This approach targets aging biology to potentially enhance longevity.

  • Goal: Develop safer, more effective mTOR inhibitors to extend health span.
  • Proof: mTOR inhibitors regulate longevity across species, suggesting potential human benefits.
  • Nuances:
    • Dr. Mannick combines expertise from academia and biotech.
    • Tornado Therapeutics focuses on longevity through mTOR research.
  • Impact on Life: Could lead to increased life quality and longevity through scientific advancements.

Investments

  • Price: Estimated $50-100 million for drug development
  • Time: Years of research and clinical trials
  • Effort: High scientific and regulatory effort required

Risks

Ongoing development; effectiveness in humans still under study.

Alternatives

  • Dietary restrictions that naturally inhibit mTOR
  • Exercise routines known to moderate mTOR activity

Get Started 🚀

  • Stay informed about clinical trials
  • Follow Tornado Therapeutics' updates
  • Consider lifestyle changes that naturally moderate mTOR

Brogevity AI can make mistakes. Check important info.

Reference Video